One surgery instead of two? new coating may fight hip implant infections

NCT ID NCT04251377

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study compares a single-stage surgery using implants coated with an antibiotic-loaded hydrogel to the standard two-stage surgery for treating chronic hip prosthesis infections. The single-stage approach aims to remove the infected implant and place a new one in the same operation, potentially reducing hospital stays and complications. The trial includes 39 adults with confirmed hip implant infections and will track infection recurrence and hip function over time.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

antibiotic-loaded hydrogel coating (DAC® gel) applied to hip implants

What this could lead to

If successful, this single-stage approach could become a simpler, faster treatment for hip implant infections, reducing the need for a second surgery and lengthy recovery.

What could go wrong

This is a small, early-phase trial with only 39 participants, so results may not apply broadly. The single-stage surgery may still fail to control infection as effectively as the standard two-stage approach.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HIP PROSTHESIS INFECTION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

periprosthetic joint infection Persistent Infection prosthesis-related infectious disease split hand-foot malformation 3

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • CHU Amiens

    Amiens, France

  • CHU Bordeaux

    Bordeaux, France

  • CHU Caen

    Caen, France

  • CHU Clermont-Ferrand

    Clermont-Ferrand, France

  • CHU Dijon

    Dijon, France

  • CHU Lille

    Lille, France

  • CHU Marseille

    Marseille, France

  • CHU Nancy

    Nancy, France

  • CHU Nantes

    Nantes, France

  • CHU Nice

    Nice, France

  • CHU Toulouse

    Toulouse, France

  • Chu Saint-Etienne

    Saint-Etienne, France

  • HCL - Hôpital Edouard Herriot

    Lyon, France

  • HCL - Hôpital de la Croix Rousse

    Lyon, France